New Rochelle, NY, November 30, 2015--The higher rate of cancer-related deaths among racial minorities has often been attributed to disparities in cancer screening compliance, however, a new study did not find that the association between body weight/obesity, in particular, and cancer screening adherence vary by race/ethnicity. The results of this focused look at one particular factor, body mass index (BMI) as a measure of obesity, suggests that some screening disparities may be decreasing, as reported in the study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health website until December 31, 2015.
In "Racial/Ethnic Differences Affecting Adherence to Cancer Screening Guidelines Among Women", a team of researchers from University of Texas Medical Branch, Galveston, found no notable variation between racial/ethnic groups among a national sample of women classified as underweight, normal weight, overweight, or obese and their likelihood to adhere to cancer screening guidelines regarding Pap testing and mammography. One significant finding related to BMI showed that overweight black women were less likely to receive a Pap test than black women who were underweight or normal weight.
Jacqueline Hirth, PhD, MPH, Tabassum Haque Laz, MBBS, PhD, Mahbubur Rahman, MBBS, PhD, MPH, and Abbey Berenson, MD, PhD, identified age, insurance coverage, and income as factors associated with disparities in cancer screening compliance among racial/ethnic groups in the national sample of women included in the study.
"This study adds to our understanding of variations in compliance with cancer screening guidelines among racial/ethnic groups," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.
Research reported in this publication was supported by the National Center for Advancing Translational Sciences under Award Number UL1TR000071 and the National Institute of Allergy and Infectious Diseases under Award Number K12HD052023. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
About the Journal
Journal of Women's Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. Led by Editor-in-Chief Susan G. Kornstein, MD, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health, the Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women's healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women's Health website. Journal of Women's Health is the official journal of the Academy of Women's Health and the Society for Women's Health Research.
About the Academy
Academy of Women's Health is an interdisciplinary, international association of physicians, nurses, and other health professionals who work across the broad field of women's health, providing its members with up-to-date advances and options in clinical care that will enable the best outcomes for their women patients. The Academy's focus includes the dissemination of translational research and evidence-based practices for disease prevention, diagnosis, and treatment of women across the lifespan. Journal of Women's Health and the Academy of Women's Health are co-presenters of Women's Health 2016: The 24th Annual Congress which will take place April 14-17, 2016 in Washington, DC.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including LGBT Health, Population Health Management, and Breastfeeding Medicine. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.